WHO EML Cancer Medicines Working Group (CMWG), Report of the meeting 22 – 23 March 2018. Geneva, Switzerland World Health Organization; 2018
(2018; 14 pages)

At the Seventieth World Health Assembly in 2017, World Health

Organization (WHO) Member States adopted resolution WHA70.12, Cancer prevention and control in the context of an integrated approach, and WHO was requested to prepare a technical report on pricing approaches for cancer medicines for presentation to the Executive Board. A cancer medicines working group (CMWG) was convened by WHO in March 2018 at the recommendation of the WHO Expert Committee on the Selection and Use of Essential Medicines. The CMWG aims to obtain relevant input from experts to guide the selection of optimal cancer medicines under consideration for inclusion in the Essential Medicines List (EML).

Related documents
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019